(5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione
C96H87N21O24 — CID 161157827
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione
(5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione (PubChem CID 161157827) has the molecular formula C96H87N21O24 and a molecular weight of 1918.87 g/mol. Its IUPAC name is (5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione.
Molecular Properties
| Compound Name | (5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione |
|---|---|
| PubChem CID | 161157827 |
| Molecular Formula | C96H87N21O24 |
| Molecular Weight | 1918.87 g/mol |
| Exact Mass | 1917.62 |
| IUPAC Name | (5S)-5-imidazo[1,2-a]pyrimidin-2-yl-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;5-[2-[(4S)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]furo[2,3-b]pyridin-5-yl]-5-methylimidazolidine-2,4-dione;3-[[2-[(3R)-3-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxopyrrolidin-3-yl]-1-benzofuran-5-yl]methyl]-1,1-dimethylurea;(5S)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[5-(5-methyl-3-propan-2-yloxy-1,2-oxazol-4-yl)furo[2,3-b]pyridin-2-yl]imidazolidine-2,4-dione |
| SMILES | COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cc4cc(-c5c(OC(C)C)noc5C)cnc4o3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cc4cc(C5(C)NC(=O)NC5=O)cnc4o3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cc4cc(CNC(=O)N(C)C)ccc4o3)CC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cn4cccnc4n3)NC(=O)NC1=O)C2 |
| InChI | InChI=1S/C27H25N5O7.C26H26N4O6.C24H20N6O7.C19H16N6O4/c1-13(2)37-23-21(14(3)39-31-23)17-7-16-8-20(38-22(16)28-10-17)27(25(34)29-26(35)30-27)12-32-11-15-5-6-18(36-4)9-19(15)24(32)33;1-29(2)25(34)27-12-15-4-7-20-17(8-15)9-21(36-20)26(11-22(31)28-24(26)33)14-30-13-16-5-6-18(35-3)10-19(16)23(30)32;1-23(19(32)26-21(34)28-23)13-5-12-6-16(37-17(12)25-8-13)24(20(33)27-22(35)29-24)10-30-9-11-3-4-14(36-2)7-15(11)18(30)31;1-29-12-4-3-11-8-25(15(26)13(11)7-12)10-19(16(27)22-18(28)23-19)14-9-24-6-2-5-20-17(24)21-14/h5-10,13H,11-12H2,1-4H3,(H2,29,30,34,35);4-10H,11-14H2,1-3H3,(H,27,34)(H,28,31,33);3-8H,9-10H2,1-2H3,(H2,26,28,32,34)(H2,27,29,33,35);2-7,9H,8,10H2,1H3,(H2,22,23,27,28)/t27-;26-;23?,24-;19-/m0100/s1 |
| InChIKey | UPNJFIAKOVEZDQ-HBKLPJAZSA-N |
| XLogP | 6.44 |
| TPSA | 560.12 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 141 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1918.87 |
| LogP ≤ 5 | 6.44 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161157827 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.